Pathologic manifestations of levamisole-adulterated cocaine exposure

Diagnostic Pathology

Kuang-Yu Jen¹  Amber L Nolan¹ 

[1] Department of Pathology, University of California San Francisco, 513 Parnassus Avenue, San Francisco 94143, CA, USA

关键词: Cocaine;    Levamisole;    Vasculitis;    Leukocytoclastic;    Glomerulonephritis;    Pauci-immune;    Anti-neutrophil cytoplasmic antibody;   

Others  :  1214031
DOI  :  10.1186/s13000-015-0279-z

 received in 2014-07-22, accepted in 2015-04-16,  发布年份 2015

【 摘 要 】

ᅟ

Rheumatic manifestations of cocaine have been well described, but more recently, a dramatic increase in the levamisole-adulterated cocaine supply in the United States has disclosed unique pathologic consequences that are distinct from pure cocaine use. Most notably, patients show skin lesions and renal dysfunction in the setting of extremely high perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA). Unexpectedly, antibodies to myeloperoxidase, the typical target of p-ANCA, are relatively low if at all present. This discrepancy is due to the fact that p-ANCA seen in association with levamisole-adulterated cocaine exposure is often directed against atypical p-ANCA-associated antigens within the neutrophil granules such as human neutrophil elastase, lactoferrin, and cathepsin G. Biopsies of the skin lesions reveal leukocytoclastic vasculitis often involving both superficial and deep dermal vessels. Renal injury most typically manifests as crescentic and necrotizing pauci-immune glomerulonephritis. In this review, the manifestations of levamisole-adulterated cocaine-induced vasculitis are discussed with an emphasis on the typical histomorphologic findings seen on biopsy.

Virtual Slides

The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1764738711370019 webcite.

【 授权许可】

   
2015 Nolan and Jen; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Graf J. Rheumatic manifestations of cocaine use. Curr Opin Rheumatol. 2013; 25(1):50-5.
• [2]Neynaber S, Mistry-Burchardi N, Rust C, Samtleben W, Burgdorf WH, Seitz MA et al.. PR3-ANCA-positive necrotizing multi-organ vasculitis following cocaine abuse. Acta Derm Venereol. 2008; 88(6):594-6.
• [3]Tervaert JW, Stegeman CA. A difficult diagnosis. Lancet. 2004; 364(9442):1313-4.
• [4]Rowshani AT, Schot LJ, ten Berge IJ. c-ANCA as a serological pitfall. Lancet. 2004; 363(9411):782.
• [5]Trimarchi M, Gregorini G, Facchetti F, Morassi ML, Manfredini C, Maroldi R et al.. Cocaine-induced midline destructive lesions: clinical, radiographic, histopathologic, and serologic features and their differentiation from Wegener granulomatosis. Medicine. 2001; 80(6):391-404.
• [6]Perez Alamino R, Espinoza LR. Vasculitis mimics: cocaine-induced midline destructive lesions. Am J Med Sci. 2013; 346(5):430-1.
• [7]Espinoza LR, Perez AR. Cocaine-induced vasculitis: clinical and immunological spectrum. Curr Rheumatol Rep. 2012; 14(6):532-8.
• [8]Wiesner O, Russell KA, Lee AS, Jenne DE, Trimarchi M, Gregorini G et al.. Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum. 2004; 50(9):2954-65.
• [9]Sercarz JA, Strasnick B, Newman A, Dodd LG. Midline nasal destruction in cocaine abusers. Otolaryngology–head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck. Surgery. 1991; 105(5):694-701.
• [10]Davin JC, Merkus MP. Levamisole in steroid-sensitive nephrotic syndrome of childhood: the lost paradise? Pediatr Nephrol. 2005; 20(1):10-4.
• [11]Hobday TJ, Erlichman C. Adjuvant therapy of colon cancer: a review. Clin Colorectal Cancer. 2002; 1(4):230-6.
• [12]Boyer O, Moulder JK, Grandin L, Somers MJ. Short- and long-term efficacy of levamisole as adjunctive therapy in childhood nephrotic syndrome. Pediatr Nephrol. 2008; 23(4):575-80.
• [13]Lee KC, Ladizinski B, Federman DG. Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge. Mayo Clin Proc. 2012; 87(6):581-6.
• [14]Mielants H, Veys EM. A study of the hematological side effects of levamisole in rheumatoid arthritis with recommendations. J Rheumatol Suppl. 1978; 4:77-83.
• [15]Symoens J, Veys E, Mielants M, Pinals R. Adverse reactions to levamisole. Cancer Treat Rep. 1978; 62(11):1721-30.
• [16]Menni S, Pistritto G, Gianotti R, Ghio L, Edefonti A. Ear lobe bilateral necrosis by levamisole-induced occlusive vasculitis in a pediatric patient. Pediatr Dermatol. 1997; 14(6):477-9.
• [17]Rongioletti F, Ghio L, Ginevri F, Bleidl D, Rinaldi S, Edefonti A et al.. Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol. 1999; 140(5):948-51.
• [18]Buchanan JA, Heard K, Burbach C, Wilson ML, Dart R. Prevalence of levamisole in urine toxicology screens positive for cocaine in an inner-city hospital. JAMA. 2011; 305(16):1657-8.
• [19]Lynch KL, Dominy SS, Graf J, Kral AH. Detection of levamisole exposure in cocaine users by liquid chromatography-tandem mass spectrometry. J Anal Toxicol. 2011; 35(3):176-8.
• [20]Czuchlewski DR, Brackney M, Ewers C, Manna J, Fekrazad MH, Martinez A et al.. Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol. 2010; 133(3):466-72.
• [21]Arora NP, Jain T, Bhanot R, Natesan SK. Levamisole-induced leukocytoclastic vasculitis and neutropenia in a patient with cocaine use: an extensive case with necrosis of skin, soft tissue, and cartilage. Addict Sci Clin Pract. 2012; 7(1):19.
• [22]Chang A, Osterloh J, Thomas J. Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther. 2010; 88(3):408-11.
• [23]McGrath MM, Isakova T, Rennke HG, Mottola AM, Laliberte KA, Niles JL. Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol. 2011; 6(12):2799-805.
• [24]Graf J, Lynch K, Yeh CL, Tarter L, Richman N, Nguyen T et al.. Purpura, cutaneous necrosis, and antineutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine. Arthritis Rheum. 2011; 63(12):3998-4001.
• [25]Gao Y, Zhao MH. Review article: Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology. 2009; 14(1):33-41.
• [26]Friedman DR, Wolfsthal SD. Cocaine-induced pseudovasculitis. Mayo Clin Proc. 2005; 80(5):671-3.
• [27]Chai PR, Bastan W, Machan J, Hack JB, Babu KM. Levamisole exposure and hematologic indices in cocaine users. Acad Emerg Med. 2011; 18(11):1141-7.
• [28]Parkinson DR, Cano PO, Jerry LM, Capek A, Shibata HR, Mansell PW et al.. Complications of cancer immunotherapy with levamisole. Lancet. 1977; 1(8022):1129-32.
• [29]Amery WK, Butterworth BS. The dosage regimen of levamisole in cancer: is it related to efficacy and safety? Int J Immunopharmacol. 1983; 5(1):1-9.
• [30]Kallenberg CG, Stegeman CA, Abdulahad WH, Heeringa P. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention. Am J Kidney Dis. 2013; 62(6):1176-87.
• [31]Arora NP. Cutaneous vasculopathy and neutropenia associated with levamisole-adulterated cocaine. Am J Med Sci. 2013; 345(1):45-51.
• [32]Walsh NM, Green PJ, Burlingame RW, Pasternak S, Hanly JG. Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole. J Cutan Pathol. 2010; 37(12):1212-9.
• [33]Gaertner EM, Switlyk SA. Dermatologic complications from levamisole-contaminated cocaine: a case report and review of the literature. Cutis. 2014; 93(2):102-6.
• [34]Gulati S, Donato AA. Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature. J Thromb Thrombolysis. 2012; 34(1):7-10.
• [35]Carlson AQ, Tuot DS, Jen KY, Butcher B, Graf J, Sam R et al.. Pauci-immune glomerulonephritis in individuals with disease associated with levamisole-adulterated cocaine: a series of 4 cases. Medicine. 2014; 93(17):290-7.
• [36]Sharff JA. Renal infarction associated with intravenous cocaine use. Ann Emerg Med. 1984; 13(12):1145-7.
• [37]Goodman PE, Rennie WP. Renal infarction secondary to nasal insufflation of cocaine. Am J Emerg Med. 1995; 13(4):421-3.
• [38]Gu X, Herrera GA. Thrombotic microangiopathy in cocaine abuse-associated malignant hypertension: report of 2 cases with review of the literature. Arch Pathol Lab Med. 2007; 131(12):1817-20.
• [39]Karch SB, Defraia B, Messerini L, Mari F, Vaiano F, Bertol E. Aminorex associated with possible idiopathic pulmonary hypertension in a cocaine user. Forensic Sci Int. 2014; 240:e7-10.
• [40]Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, Kallenberg CG et al.. Prediction of relapses in Wegener’s granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum. 2000; 43(9):2025-33.
• [41]Tomasson G, Grayson PC, Mahr AD, Lavalley M, Merkel PA. Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis–a meta-analysis. Rheumatology. 2012; 51(1):100-9.
• [42]Bansal PJ, Tobin MC. Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol. 2004; 93(4):398-401.
• [43]Silva F, Specks U, Sethi S, Irazabal MV, Fervenza FC. Successful pregnancy and delivery of a healthy newborn despite transplacental transfer of antimyeloperoxidase antibodies from a mother with microscopic polyangiitis. Am J Kidney Dis. 2009; 54(3):542-5.
• [44]Ooi JD, Chang J, Hickey MJ, Borza DB, Fugger L, Holdsworth SR et al.. The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis. Proc Natl Acad Sci U S A. 2012; 109(39):E2615-24.
• [45]Nakazawa D, Tomaru U, Suzuki A, Masuda S, Hasegawa R, Kobayashi T et al.. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2012; 64(11):3779-87.
• [46]Wolford A, McDonald TS, Eng H, Hansel S, Chen Y, Bauman J et al.. Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement. Drug Metab Dispos. 2012; 40(6):1067-75.